![New Tech Could Improve Diagnostic Accuracy of Prostate Cancer Tests](https://www.g2intelligence.com/wp-content/uploads/2023/03/Apr23.DTET_.ProstateCancerDiagnostics-iStock-1800x1250-1-1080x675.jpg)
New Tech Could Improve Diagnostic Accuracy of Prostate Cancer Tests
New technologies show potential for far greater accuracy and the ability to customize treatment options to improve outcomes.
New technologies show potential for far greater accuracy and the ability to customize treatment options to improve outcomes.
The personalized test is designed to help inform post-surgery adjuvant therapies in CRC patients.
Recently released AACC document covers newly updated screening guidelines as well as information on surveillance and diagnosis.
Though not yet recommended for screening by the ACS or other medical groups, recently developed blood-based tests show promise.
The health plan issued a new policy expanding coverage of molecular genetic tests for personalized cancer diagnosis, prognosis, and treatment.